Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 5, 2006
Patent Application Number
10827673
Date Filed
April 19, 2004
Patent Citations Received
Patent Primary Examiner
Patent abstract
A method for promoting angiogenesis in a patient comprising providing crosslinkable biological solution to the target tissue, wherein the crosslinkable biological solution is loaded with at least one angiogenic agent. In one embodiment, the at least one angiogenic agent is a non-protein factor selected from a group consisting of ginsenoside Rg1, ginsenoside Re, combination thereof and the like. In another embodiment, the crosslinkable biological solution of the present invention is broadly defined in a form or phase of solution, paste, gel, suspension, colloid or plasma that may be solidifiable thereafter.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.